Fig. 2From: The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort studyDistributions of different stroke prevention strategies in different CHA2DS2-VASc and HAS-BLED scores. AP = anti-platelet agents; NOACs = non–vitamin K antagonist oral anticoagulantsBack to article page